ATLAS Market profile
Menu
Atlas · Symbols · Stocks & Shares · 2696

Atlas market file · Equity · Asia-Pacific

Shanghai Henlius Biotech, Inc. Class H2696

Last close
60.1
Change
+8.00%
96-bar range
50.25 – 87.1
As of
3 Aug 2026

Shanghai Henlius Biotech, Inc. Class H is a healthcare or life-sciences issuer listed as 2696 on HKEX. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
HKEX symbol identity
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot HKEX:2696

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

88.205578.440268.67558.909749.144512 Mar26 May03 Aug

up candle   down candle

Latest close60.1
Day change+8.00%
Window high87.1
Window low50.25
96-bar change-11.16%
SnapshotDaily · 96 bars
As of2026-08-03 01:30 UTC

Weekly outlook: the last 104 weekly closes (+162.45% over the window).

87.18413.36618 Aug03 Aug

Source rail: Yahoo Finance chart API (2696.HK). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView · provider feed Open view

Open the attributed TradingView market view for 2696. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

2696 public profile

Company

Healthcare or life-sciences issuer. Shanghai Henlius Biotech, Inc. Class H is connected to current market context, cited company sources and its retained research file.

Market

Shanghai Henlius Biotech, Inc. Class H trades as 2696 on HKEX. Shanghai Henlius Biotech, Inc. Class H (2696) has a latest verified close of 60.1, up 8.00%, dated 3 Aug 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files 2696 under Technology Stocks and Science & Biotech Stocks for browsing.

Institutional Market Wit ● Sourced Research File

Shanghai Henlius Biotech, Inc. Class H does not become simple just because 2696 looks tidy. Shanghai Henlius Biotech, Inc. Class H is listed on HKEX in Asia-Pacific with TradingView symbol HKEX:2696 and public listing evidence. The market can compress a company into four letters, but the real story still has departments, customers, product choices, capital needs, margins, competitors, and the occasional executive sentence trying to sound heavier than it is. A listed company earns a wider paragraph through evidence, not adjectives, so the useful next step for 2696 is the specific filing, earnings line, or ownership change that turns today's outline into something a reader can check (source: public profile, https://atlas.freedomcore.io/stocks/2696/).

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Daily answer

What changed for Shanghai Henlius Biotech, Inc. Class H today

Open full report
2696 daily contextvalidated public digest2 source rail2026-07-30 21:03 UTC

Shanghai Henlius Biotech, Inc. Class H (2696) is tracked as a listed company on HKEX. The public profile anchors the symbol identity, region, chart route, and research-only context for the Asia-Pacific market before any daily source layer is added.

2696 is handled first as a equity file: identity, listing route, source trail, chart context, and the current limits of the public evidence set.

The deeper daily research layer expands only when fresh evidence changes the file. Until then, this page keeps the public profile, chart route, risks, catalysts, and research-only framing explicit instead of manufacturing movement for its own sake.

Sources & evidence · 1 links

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
2696
Exchange
HKEX
Sector
Equity Global Directory
Region
Asia-Pacific
Asset class
Equity
TradingView

2696 technical readout

Trend strength (ADX 14)
16.2
Average true range (ATR 14)
4.3626
ATR as % of price
8.33%
Volatility compression (ATR14/ATR50)
1.01x

Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-29. Indicators are descriptive statistics, not investment advice.

Source authority

2696 evidence rails

Atlas uses the specific public rails available for 2696: HKEX symbol identity, TradingView, FRED, Atlas methodology. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence · 4 rails

Open an Atlas research path on 2696

FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for 2696 Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep 2696 research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

2696 FAQ

What is Shanghai Henlius Biotech, Inc. Class H (2696)?Shanghai Henlius Biotech, Inc. Class H (2696) has a latest verified close of 60.1, up 8.00%, dated 3 Aug 2026. Use this page to check the price chart, company context,...

Shanghai Henlius Biotech, Inc. Class H (2696) has a latest verified close of 60.1, up 8.00%, dated 3 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for 2696?Shanghai Henlius Biotech, Inc. Class H (2696) has a latest verified close of 60.1, up 8.00%, dated 3 Aug 2026. It brings the latest available chart, company context,...

Shanghai Henlius Biotech, Inc. Class H (2696) has a latest verified close of 60.1, up 8.00%, dated 3 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files 2696 under Technology Stocks and Science & Biotech Stocks for browsing.

How often is the 2696 page updated?The 2696 public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The 2696 public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for 2696?The 2696 file starts with HKEX symbol identity and TradingView HKEX:2696. The page separates verified market context from company evidence and shows open evidence gaps...

The 2696 file starts with HKEX symbol identity and TradingView HKEX:2696. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on 2696?Yes. The workstation can open 2696, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open 2696, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this 2696 page investment advice?No. The 2696 page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The 2696 page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-07-30. Browse FreedomCore Atlas research notes →